Study #2023-0571
A phase 1/2 study of KSQ-001EX, autologous tumor Infiltrating Lymphocytes engineered to inactivate the SOCS1 gene, in patients with select advanced solid tumors
MD Anderson Study Status
Enrolling
Treatment Agent
KSQ-001EX, Cyclophosphamide, Fludarabine, Interleukin-2
Description
To learn if KSQ-001EX is safe to give to participants with advanced forms of solid tumors.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Advanced Solid Tumor, Melanoma, Lung Neoplasms, Head and Neck Neoplasms
Study phase:
Physician name:
Rodabe Amaria
Department:
Melanoma Medical Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.